Notable analyst calls this week: Paypal, Rivian and Merck among top picks
at seekingalpha.com (Sat, 20-Dec 9:11 AM)
RXRX, FTNT, MRK, RIVN, PYPL Trending With Analysts
at www.tipranks.com (Sat, 20-Dec 4:03 AM)
at www.benzinga.com (Sat, 20-Dec 1:38 AM)
Bullish On MRK? You Might Want To Consider This Credit Put Spread Expiring in 9 Days
Market Chameleon (Fri, 19-Dec 1:10 PM)
5 “High-Yield Dividend” Stocks Poised for Growth in 2026
at www.tipranks.com (Fri, 19-Dec 3:39 PM)
Market Voices: Trump on Venezuela, CPI data issues, drug pricing deals
at seekingalpha.com (Fri, 19-Dec 1:08 PM)
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out
at www.benzinga.com (Fri, 19-Dec 12:43 PM)
Analysts Sound Alarm On Pyxis Oncology's Tiny Trial
at www.benzinga.com (Fri, 19-Dec 9:07 AM)
Jefferies Keeps Their Buy Rating on Merck & Company (MRK)
at www.tipranks.com (Fri, 19-Dec 9:07 AM)
Merck & Company (MRK) Gets a Buy from Scotiabank
at www.tipranks.com (Fri, 19-Dec 8:26 AM)
AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters
at seekingalpha.com (Fri, 19-Dec 6:53 AM)
Medicare-negotiated drug prices to halve out-of-pocket costs next year: report
at seekingalpha.com (Thu, 18-Dec 12:30 PM)
Pyxis plummets following phase 1 data on candidate for head and neck cancer
at seekingalpha.com (Thu, 18-Dec 11:53 AM)
Bullish On MRK? You Might Want To Consider This Credit Put Spread Expiring in 17 Days
Market Chameleon (Wed, 26-Nov 1:10 PM)
Merck Expands Hematology Pipeline With Diverse Data Unveiled for Novel Therapeutics at ASH 2025
Market Chameleon (Mon, 24-Nov 7:07 AM)
Merck Declares $0.85 Dividend for Q1 2026—What Does This Signal for Investors?
Market Chameleon (Tue, 18-Nov 11:47 AM)
Market Chameleon (Tue, 18-Nov 7:11 AM)
Market Chameleon (Fri, 14-Nov 7:56 AM)
Merck’s Pipeline and Strategic Expansion Drive Strong Q3 Results and Raise 2025 Outlook
Market Chameleon (Thu, 30-Oct 7:11 AM)
